Showing results (191-200 of 269) with videos related to

Sort By:
Pageof 27
Leukemia & Lymphoma|November 1, 2022
Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantationDamian Mikulski, Kacper Kościelny, Mateusz Nowicki, et al.
Pediatric Endocrinology, Diabetes, and Metabolism|June 7, 2013
Multicenter cross-sectional analysis of values of glycated haemoglobin (HbA1c) in Polish children and adolescents with long-term type 1 diabetes in Poland: PolPeDiab study groupPrzemysława Jarosz-Chobot, Joanna Polańska, Małgorzata Myśliwiec, et al.
Journal of Clinical Medicine|June 24, 2022
mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum ProfileBartłomiej Pawlik, Urszula Smyczyńska, Szymon Grabia, et al.
Journal of Psychosomatic Research|July 14, 2010
Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS StudyJakub Kazmierski, Maciej Kowman, Maciej Banach, et al.
Acta Diabetologica|February 20, 2014
Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol levelWojciech Fendler, Manfredi Rizzo, Maciej Borowiec, et al.
Mediators of Inflammation|June 27, 2020
Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with BortezomibPaweł Robak, Edyta Węgłowska, Izabela Dróżdż, et al.
Radiation Oncology (London, England)|April 28, 2016
Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancerTru-Khang T Dinh, Wojciech Fendler, Justyna Chałubińska-Fendler, et al.
Cancers|March 6, 2021
The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with BortezomibPawel Robak, Dariusz Jarych, Damian Mikulski, et al.
Cancers|June 14, 2020
TP53-Deficient Angiosarcoma Expression Profiling in Rat ModelUrszula Smyczyńska, Damian Strzemecki, Anna M Czarnecka, et al.
DNA and Cell Biology|February 11, 2014
TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation statusDorota Jesionek-Kupnicka, Malgorzata Szybka, Beata Malachowska, et al.
Pageof 27